Drug Importation Is A High-Profile Addition To US FDA’s Regulatory Agenda
Executive Summary
Agency is targeting January 2020 for release of controversial proposed rule to allow importation of certain types of prescription drugs from Canada; although most Rx drug-related proposed and final rules on the Fall 2019 regulatory agenda are making repeat appearances, a final rule on electronic distribution of prescribing information has fallen off the list.
You may also be interested in...
US FDA Patient Medication Information Proposed Rule May Be Coming Soon
A proposal for a new form of patient labeling, which has been in the works for decades, may finally be coming to fruition despite the FDA missing a December 2022 target date listed in HHS’ semi-annual regulatory agenda.
The FDA Commissioner Shuffle And Canadian Rx Imports
Upcoming proposed rule will create a process for third parties (notably including the state of Florida) to begin importing drugs wholesale from Canada. It will be an FDA rule – though FDA has had very little input in it.
Canadian Importation Option May Be Hindered By Product, Savings Restrictions
Many of the products most commonly sighted as in need of a price break are not eligible under the legal framework described.